| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. | Director | Common Stock, par value $0.0001 per share | 6.19K | $127K | $20.50 | Oct 20, 2025 | Direct |
| Corbus Pharmaceuticals Holdings, Inc. | Director | Stock options (right to buy) | 4.25K | Oct 20, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | Oct 20, 2025 | 3 | -$16.6K | 4 | Oct 21, 2025 | Director |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | May 30, 2025 | 3 | -$10.1K | 4 | Jun 2, 2025 | Director |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | May 30, 2024 | 1 | $0 | 4 | Jun 3, 2024 | Director |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | May 16, 2024 | 1 | $0 | 4 | May 20, 2024 | Director |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | May 18, 2023 | 1 | $0 | 4 | May 22, 2023 | Director |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | Sep 26, 2022 | 1 | $0 | 4 | Sep 28, 2022 | Director |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | Sep 26, 2022 | 0 | $0 | 3 | Sep 28, 2022 | Director |